Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects

Jeffrey Gudin1 Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USA;2 Department of Anesthesiology and Pain Management, Englewood Hospital and Medical Center, Englewood, NJ, USAView further author information

Lynn R Webster3 Scientific Affairs Neurosciences, PRA Health Sciences, Salt Lake City, UT, USACorrespondence[email protected]
View further author information

Emileigh Greuber4 Global Research and Development and Medical Affairs, Scilex Pharmaceuticals Inc, Palo Alto, CA, USA

https://orcid.org/0000-0001-6450-1988 View further author information

Kip Vought4 Global Research and Development and Medical Affairs, Scilex Pharmaceuticals Inc, Palo Alto, CA, USAView further author information

Kalpana Patel4 Global Research and Development and Medical Affairs, Scilex Pharmaceuticals Inc, Palo Alto, CA, USAView further author information

Louis Kuritzky5 Community Health and Family Medicine, University of Florida Community Health & Family Medicine, Gainesville, FL, USAView further author information

Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects

Citations (3)

Read on this site (2)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date